The recent surge in SpaceX’s valuation has caught the eye of UK regulators, who now warn that the private company’s secondary market trading could trigger contagion across the broader financial system. As the Chief Financial Editor with two decades in the City, I find this development both fascinating and deeply troubling.
SpaceX, Elon Musk’s rocket venture, has seen its implied valuation balloon to nearly $180 billion in recent private transactions. But unlike publicly listed equities, these shares trade in a murky secondary market where disclosure is minimal and liquidity is a myth. The Financial Conduct Authority has quietly expressed concern that a sudden revaluation of SpaceX could create a domino effect among the institutional investors and hedge funds that have piled into this space race.
Let’s be clear: this is not a story about space exploration. It is a story about capital flight, yield starvation, and the dangerous hunt for unicorn returns. With UK gilt yields still below inflation, pension funds and insurance giants have been forced to chase alternative assets. SpaceX offers a compelling narrative: rockets, Mars, and monopoly-like dominance in orbital launches. But the financial engineering behind these trades is opaque at best.
The problem is valuation. SpaceX is not listed, so its price is set by a handful of broker-dealers matching buyers and sellers. These transactions, often conducted via platforms like Forge Global, are illiquid and prone to herd behaviour. A sudden rush for the exit, perhaps triggered by a regulatory crackdown or a missed production target, could leave investors holding overpriced paper with no buyers. The FCA fears this could spill into the broader market, forcing fire sales of other assets and amplifying volatility.
This is not mere theoretical navel-gazing. We have seen this movie before. The 2021 Archegos blow-up showed how concentrated bets in opaque markets can cause billions in losses for prime brokers. The FCA’s warning is a thinly veiled reminder that the same can happen with private tech behemoths. And with SpaceX’s constellation of Starlink satellites and the Starship programme requiring massive capital, the risk of a funding crunch is real.
Moreover, the market’s obsession with SpaceX is a symptom of a deeper malaise. Central banks have kept interest rates artificially low for too long, driving investors into speculative assets. The recent rise in long-term gilt yields should theoretically puncture this bubble, but instead, the chase for growth has intensified. UK regulators are right to be worried: a correction in private market valuations could trigger a reassessment of risk premiums across the board, hitting everything from AIM-listed growth stocks to corporate bonds.
What can be done? The FCA should demand greater transparency in secondary market transactions. If these shares are to be treated as quasi-public instruments, then they must adhere to disclosure standards that allow investors to price risk accurately. But let’s not hold our breath. The government’s obsession with promoting the UK as a tech hub means it will be reluctant to impose rules that might scare off capital. So, for now, we are left with a high-stakes gamble where the house often wins, but the punters can be wiped out.
The bottom line: SpaceX’s stock surge is a canary in the coal mine for frothy private markets. UK regulators are humming the right tune, but they may be too late to prevent the contagion they fear. Investors should fasten their seatbelts. The rocket ride might end with a thud.
